The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MM-007: A phase 3 trial comparing the efficacy and safety of pomalidomide (POM), bortezomib (BORT), and low-dose dexamethasone (LoDEX [PVD]) versus BORT and LoDEX (VD) in subjects with relapsed or refractory multiple myeloma (RRMM).
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Johnson & Johnson; Takeda
 
Amine Bensmaine
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Thomas Doerr
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Jianming Wang
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Mohamed H. Zaki
Employment - Celgene
Stock and Other Ownership Interests - Celgene